Table 1.
Parameters | CAD patients (n = 102) | Controls (n = 89) | P Value |
---|---|---|---|
Age (y) | 60.3 ± 9.4 | 58.2 ± 8.0 | .100 |
Gender (Male/Female) | 74/28 | 64/25 | .922 |
BMI (kg/m2) | 24.8 ± 3.4 | 23.9 ± 3.7 | .082 |
Hypertension (n/%) | 85 (83.3) | 55 (61.8) | <.001 |
Diabetes (n/%) | 31 (30.4) | 16 (18.0) | .047 |
Smoke (n/%) | 53 (52.0) | 42 (41.2) | .511 |
Family history of CAD (n/%) | 47 (46.1) | 26 (29.2) | .017 |
TG (mmol/L) | 1.81 ± 0.96 | 1.72 ± 0.71 | .468 |
TC (mmol/L) | 4.53 ± 1.60 | 4.04 ± 1.38 | .026 |
HDL‐C (mmol/L) | 1.01 ± 0.36 | 1.15 ± 0.40 | .012 |
LDL‐C (mmol/L) | 2.99 ± 1.13 | 2.63 ± 0.81 | .013 |
Gensini Score | 47.50 (24.63‐74.00) | 1.00 (1.00‐2.00) | <.001 |
BMI, body mass index; CAD, coronary artery disease; HDL‐C, fasting high‐density lipoprotein cholesterol; LDL‐C, fasting low‐density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.
Data were presented as mean value ± standard deviation, median and 25th‐75th value or count (percentage). Significance of the comparison was determined by t test, Wilcoxon rank sum test or Chi‐square test. P Value <.05 was considered significant. Bold values indicate the statistical significance.